When did Celldex Therapeutics report Q4 2024 earnings?

Celldex Therapeutics (CLDX) reported Q4 2024 earnings on February 27, 2025 before market open.

What were Celldex Therapeutics's Q4 2024 revenue and EPS?

Celldex Therapeutics reported revenue of $1.2M and eps of $-0.71 for Q4 2024.

Did Celldex Therapeutics beat estimates in Q4 2024?

Revenue missed the consensus estimate of $1.3M by $77.0K. EPS beat the consensus estimate of $-0.73 by $0.02.

Where can I find Celldex Therapeutics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001410578-25-000216) directly on SEC EDGAR. The filing index links above go to sec.gov.

Celldex Therapeutics CLDX Q4 2024 Annual earnings

Reported February 27, 2025 · Before market open

Revenue$1.2MMiss by $77.0K

EPS-$0.71Beat by $0.02

Revenue estimate$1.3M

EPS estimate-$0.73

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$734.9K

EPS estimate-$1.04

Financials

Q4 2024

Income statement

See full

Revenue$1.2M-71.6%

Operating income-$56.0M-17.6%

Net income-$47.1M-8.7%

EPS (diluted)-$0.71+15.5%

Balance sheet

See full

Cash & equivalents$28.4M-18.6%

Total debt$3.8M+50.0%

Total equity$747.0M+74.1%

Total assets$792.3M+70.2%

Cash flow

See full

Operating cash flow-$32.5M+0.2%

CapEx$756.0K+13.5%

Free cash flow-$33.2M-0.1%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$1.68B-22.7%

Enterprise value$1.65B-22.7%

P/S238.8×-76.3×

Profitability

See full

Operating margin-2,778.9%+866pp

Net margin-2,248.8%+234pp

FCF margin-2,274.9%+1,752pp

Returns & leverage

See full

Return on equity-26.8%-5.9pp

Debt / equity0×0.0×

Current ratio18.9×+5.0×

Segments

By product

See full

Grant$1.2M-69.9%

Versus estimates

Revenue

Q1 2026$15.0KMiss by $780.4K Q4 2025$100.0KMiss by $1.2M Q2 2025$730.0KMiss by $453.9K Q1 2025$695.0KMiss by $425.8K

Q4 2024$1.2MMiss by $77.0K

Diluted EPS

Q1 2026-$1.18Miss by $0.03 Q4 2025-$1.22Miss by $0.22 Q3 2025-$1.01Miss by $0.13 Q2 2025-$0.85Beat by $0.01 Q1 2025-$0.81Miss by $0.06

Q4 2024-$0.71Beat by $0.02

Ask the moment Celldex Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Celldex Therapeutics report Q4 2024 earnings?: Celldex Therapeutics (CLDX) reported Q4 2024 earnings on February 27, 2025 before market open.
What were Celldex Therapeutics's Q4 2024 revenue and EPS?: Celldex Therapeutics reported revenue of $1.2M and eps of $-0.71 for Q4 2024.
Did Celldex Therapeutics beat estimates in Q4 2024?: Revenue missed the consensus estimate of $1.3M by $77.0K. EPS beat the consensus estimate of $-0.73 by $0.02.
Where can I find Celldex Therapeutics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001410578-25-000216) directly on SEC EDGAR. The filing index links above go to sec.gov.